Show simple item record

Can a combined screening/treatment programme prevent premature failure of renal transplants due to chronic rejection in patients with HLA antibodies: study protocol for the multicentre randomised controlled OuTSMART trial

dc.contributor.authorDorling, Aen_US
dc.contributor.authorRebollo-Mesa, Ien_US
dc.contributor.authorHilton, Ren_US
dc.contributor.authorPeacock, JLen_US
dc.contributor.authorVaughan, Ren_US
dc.contributor.authorGardner, Len_US
dc.contributor.authorDanzi, Gen_US
dc.contributor.authorBaker, Ren_US
dc.contributor.authorClark, Ben_US
dc.contributor.authorThuraisingham, RCen_US
dc.contributor.authorBuckland, Men_US
dc.contributor.authorPicton, Men_US
dc.contributor.authorMartin, Sen_US
dc.contributor.authorBorrows, Ren_US
dc.contributor.authorBriggs, Den_US
dc.contributor.authorHorne, Ren_US
dc.contributor.authorMcCrone, Pen_US
dc.contributor.authorKelly, Jen_US
dc.contributor.authorMurphy, Cen_US
dc.date.accessioned2015-09-15T09:17:32Z
dc.date.available2014-01-06en_US
dc.date.issued2014-01-21en_US
dc.identifier.issn1745-6215en_US
dc.identifier.otherARTN 30en_US
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/8664
dc.description© 2014 Dorling et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
dc.relation.ispartofTRIALSen_US
dc.subjectHuman leukocyte antigen antibodiesen_US
dc.subjectrenal transplantationen_US
dc.subjectpremature allograft failureen_US
dc.subjectchronic rejectionen_US
dc.subjectscreeningen_US
dc.subjecttacrolimusen_US
dc.subjectmycophenolate mofetilen_US
dc.subjectclinical trialen_US
dc.subjectrandomised controlled trialen_US
dc.subjectrandomized controlled trialen_US
dc.subjectKCTUen_US
dc.subjectCTUen_US
dc.subjecttrials uniten_US
dc.subjectdiabetesen_US
dc.subjectkidneyen_US
dc.subjectgraft failureen_US
dc.subjectbiomarkeren_US
dc.subjectbiomarker-led careen_US
dc.subjectDSAen_US
dc.subjectnon-DSAen_US
dc.subjectmulticentreen_US
dc.subjectimmunosuppressionen_US
dc.subjectusual careen_US
dc.subjecttreatment as usualen_US
dc.subjectstandard careen_US
dc.subjectblindeden_US
dc.subjectunblindeden_US
dc.subjectEME fundeden_US
dc.subjectNIHRen_US
dc.subjectoptimiseden_US
dc.subjectoptimizeden_US
dc.subjectintention-to-treaten_US
dc.subjectper protocolen_US
dc.titleCan a combined screening/treatment programme prevent premature failure of renal transplants due to chronic rejection in patients with HLA antibodies: study protocol for the multicentre randomised controlled OuTSMART trialen_US
dc.typeArticle
dc.identifier.doi10.1186/1745-6215-15-30en_US
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000333465400002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.notesNot knownen_US
pubs.organisational-group/Queen Mary University of London
pubs.organisational-group/Queen Mary University of London/Faculty of Medicine & Dentistry
pubs.organisational-group/Queen Mary University of London/Faculty of Medicine & Dentistry/Blizard Institute
pubs.publication-statusPublisheden_US
pubs.volume15en_US


Files in this item

Thumbnail
Name:
BUCKLANDCombinedScreening/trea ...
Size:
978.6Kb
Format:
application/
Description:
Published version
View/Open

This item appears in the following Collection(s)

Show simple item record